support thyroid research


Clinical Thyroidology for Patients

Clinical Thyroidology for Patients is a collection of summaries of recently published articles from the medical literature that covers the broad spectrum of thyroid disorders.

Starting with the May 2009 issue, Clinical Thyroidology for Patients will be published on a monthly basis and include summaries of research studies that were discussed in the previous month’s issue of Clinical Thyroidology, a publication of the American Thyroid Association for physicians. Dr. Hershman is the Editor-in-Chief of Clinical
Thyroidology.

Clinical Thyroidology
for Patients Volume 4

March 2011 Volume 4 Issue 3

Now available in pdf format for saving and printing and Web page format for viewing online

PDF Format for Saving and Printing
Clinical Thyroidology for Patients March 2011 Volume 4 Issue 3 (PDF file, 1.06 MB)

TABLE OF CONTENTS – Web Format

Editor’s Comments

THYROID SURGERY Implications of long-term hypocalcemia with normal PTH levels following thyroid surgery
Promberger et al Normal parathyroid hormone levels do not exclude permanent hypoparathyroidism after thyroidectomy. Thyroid. December 29, 2010.
(PDF File for saving and printing, 86.9 KB)

RADIOACTIVE IODINE Radioactive iodine practices in the United States
Greenlee C et al. Current safety practices relating to I-131 administration for diseases of the thyroid: a survey of physicians and allied practitioners. Thyroid. 21:151-160, 2011.
(PDF File for saving and printing, 126 KB)

THYROID CANCER Nonmedullary thyroid cancer survival is similar regardless of whether it runs in families
Robenshtok E et al. Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study. Thyroid 2011;21:43-8. Epub October 18, 2010.
(PDF File for saving and printing, 88.6 KB)

THYROID CANCER Prediction of thyroid cancer recurrence
Tuttle RM et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 2010;20:1341-9. Epub October 29, 2010.

Kloos RT. Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. J Clin Endocrinol Metab 2010;95:5241-8. Epub September 15, 2010.
(PDF File for saving and printing, 108 KB)

GRAVES’ DISEASE Management of hyperthyroidism in patients with Graves’ eye disease (orbitopathy)
Bartalena L. The dilemma of how to manage Graves’ hyperthyroidism in patients with associated orbitopathy. J Clin Endocrinol Metab. doi:10.1210/jc.2010-2329.

Elbers L, Mourits M, and Wiersinga W. Outcome of very long-term treatment with antithyroid drugs in Graves’ hyperthyroidism associated with Graves’ orbitopathy. Thyroid, December 29, 2011. doi: 10.1089/thy.2010.0181.
(PDF File for saving and printing, 106 KB)

THYROID CANCER Does analysis for the BRAF cancer-associated gene help diagnose follicular variant thyroid cancer?
 Proietti A et al BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features. Thyroid 2010;20:1263-70. Epub October 17, 2010.
(PDF File for saving and printing, 89.9 KB)

HIGHLIGHT: The Light of Life Foundation

ATA ALLIANCE FOR THYROID PATIENT EDUCATION